Skip Navigation

Clinical Trials

Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy

ClinicalTrials.gov Identifier:NCT02348593

Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA

ClinicalTrials.gov Identifier:NCT02348619

Flumazenil for the Treatment of Primary Hypersomnia

(ClinicalTrials.gov Identifier: NCT01183312)
Status:  Completed (March 2012)

Clarithromycin for the Treatment of Hypersomnia

(ClinicalTrials.gov Identifier: NCT01146600)
Status:  Completed (October 2012)